Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Drug Des Devel Ther · 2022 · PMC9508996 · PMID 36164415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Concerns about ibrutinib-associated VAs have been emerged as a result of an increasing trend reported in the VigiBase database.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.